BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 361200)

  • 1. Carcinoembryonic antigen (CEA) levels in benign gastrointestinal disease states.
    Loewenstein MS; Zamcheck N
    Cancer; 1978 Sep; 42(3 Suppl):1412-8. PubMed ID: 361200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carcinoembryonic antigen in normal and diseased liver tissue.
    Gerber MA; Thung SN
    Am J Pathol; 1978 Sep; 92(3):671-9. PubMed ID: 356625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carcinoembryonic antigen. Quantitative variations in circulating levels in benign and malignant digestive tract diseases.
    Zamcheck N
    Adv Intern Med; 1974; 19():413-33. PubMed ID: 4592719
    [No Abstract]   [Full Text] [Related]  

  • 4. Carcinoembryonic antigen in serum in diseases of the liver and pancreas.
    Khoo SK; Mackay IR
    J Clin Pathol; 1973 Jul; 26(7):470-5. PubMed ID: 4727056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison between the gastrointestinal tumor antigen and the carcinoembryonic antigen in diseases of the digestive tract].
    Tappero G; Piantino P; Cerchier A; Pecchio F
    Minerva Med; 1985 Apr; 76(16):765-70. PubMed ID: 2582313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated carcinoembryonic antigen levels and biliary tract obstruction.
    Lurie BB; Loewenstein MS; Zamcheck N
    JAMA; 1975 Jul; 233(4):326-30. PubMed ID: 1173645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum beta-N-acetyl hexosaminidase (beta-NAH) as a discriminant between malignant and benign extrahepatic biliary obstruction: comparison with carcinoembryonic antigen (CEA).
    Scapa E; Thomas P; Loewenstein MS; Zamcheck N
    Eur J Cancer Clin Oncol; 1985 Sep; 21(9):1037-42. PubMed ID: 2933260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of carcinoembryonic antigen (CEA) in bile of patients with malignant biliary tract disease.
    Konomi K; Nakamura K; Tobimatsu M; Saito S; Toyoda K; Yasunami Y
    Jpn J Surg; 1982; 12(3):184-90. PubMed ID: 7131963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Assay of the carcinoembryonic antigen (CEA) in acute and chronic liver diseases and hepatocellular carcinoma].
    Piantino P; Gallo V; Pecchio F; Garlanda PF; Bonardi O
    Minerva Med; 1981 Apr; 72(17):1059-64. PubMed ID: 6262678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunohistologic determination of a tumor marker (CEA) in diseases of the gastrointestinal tract].
    Teuber J; Meier S; Aigner K; Helmke K; Paul F; Federlin K
    Immun Infekt; 1983 May; 11(3):91-8. PubMed ID: 6373575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour marker antigen CA125 in pancreatic cancer: a comparison with CA19-9 and CEA.
    Haglund C
    Br J Cancer; 1986 Dec; 54(6):897-901. PubMed ID: 3467786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinoembryonic antigen (CEA) in patients with alcoholic liver diseases.
    Bell H; Orjasaeter H; Lange HF
    Scand J Gastroenterol; 1979; 14(3):273-9. PubMed ID: 441676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of carcinogenic embryonic antigen in differential diagnosis of diseases of pancreas and liver--a comparative study in a tertiary care hospital of Western Nepal.
    Mittal A; Farooqui SM; Pyrtuh S; Poudel B; Sathian B; Yadav SK
    Asian Pac J Cancer Prev; 2012; 13(1):275-7. PubMed ID: 22502684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carcinoembryonic antigen: clinical and historical aspects.
    Martin EW; Kibbey WE; DiVecchia L; Anderson G; Catalano P; Minton JP
    Cancer; 1976 Jan; 37(1):62-81. PubMed ID: 1247968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Carcinoembryonic antigen in liver diseases--elevated CEA levels and liver diseases with alcohol abuse (author's transl)].
    Yamaguchi N; Kimoto K; Machino M; Takeuchi S; Uozumi G; Tanaka Y; Aoike A; Kawai K
    Nihon Shokakibyo Gakkai Zasshi; 1980 Oct; 77(10):1575-80. PubMed ID: 7452949
    [No Abstract]   [Full Text] [Related]  

  • 16. Are serum and biliary carcinoembryonic antigen and carbohydrate antigen19-9 determinations reliable for differentiation between benign and malignant biliary disease?
    Akdoğan M; Parlak E; Kayhan B; Balk M; Saydam G; Sahin B
    Turk J Gastroenterol; 2003 Sep; 14(3):181-4. PubMed ID: 14655062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CEA levels in patients with colorectal polyps.
    Doos WG; Wolff WI; Shinya H; DeChabon A; Stenger RJ; Gottlieb LS; Zamcheck N
    Cancer; 1975 Dec; 36(6):1996-2003. PubMed ID: 1203857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum carcinoembryonic antigen in the differential diagnosis of pancreatic cancer: influence of tumour spread, liver impairment, and age.
    Basso D; Fabris C; Del Favero G; Angonese C; Meggiato T; Infantino A; Plebani M; Piccoli A; Leandro G; Burlina A
    Dis Markers; 1988; 6(3):203-7. PubMed ID: 3168400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma carcinoembryonic antigen in an Australian hospital population.
    Frost MA; Coates AS
    Med J Aust; 1976 Jun; 1(25):950-3. PubMed ID: 979758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The clinical significance of CEA in diseases of the gastrointestinal system, with special reference to polyps of the colon].
    Dzambas D; Svircević A; Vuković V; Borota R; Ristić Dj
    Med Pregl; 1978; 31(11-12):463-7. PubMed ID: 739953
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.